Endocrine and Neuroendocrine Cancers
Endocrine and neuroendocrine tumors originate from endocrine cells but are heterogeneous in terms of clinical presentation, disease outcome, and treatments available. This Special Issue addresses specific aspects of pre-clinical, clinical, and translational research and clinical management of these...
Zapisane w:
| Format: | Online |
|---|---|
| Język: | angielski |
| Wydane: |
MDPI - Multidisciplinary Digital Publishing Institute
2023
|
| Hasła przedmiotowe: | |
| Dostęp online: | ONIX_20230202_9783036557632_76 |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|
| _version_ | 1869524347737079808 |
|---|---|
| collection | Directory of Open Access Books |
| description | Endocrine and neuroendocrine tumors originate from endocrine cells but are heterogeneous in terms of clinical presentation, disease outcome, and treatments available. This Special Issue addresses specific aspects of pre-clinical, clinical, and translational research and clinical management of these diseases with the aim of providing novel insights, addressing current unmet needs, and discussing future treatment perspectives. |
| format | Online |
| id | doab-20.500.12854ir-96675 |
| institution | Directory of Open Access Books |
| language | eng |
| publishDate | 2023 |
| publishDateRange | 2023 |
| publishDateSort | 2023 |
| publisher | MDPI - Multidisciplinary Digital Publishing Institute |
| publisherStr | MDPI - Multidisciplinary Digital Publishing Institute |
| record_format | ojs |
| spelling | doab-20.500.12854ir-966752024-03-31T13:10:42Z Endocrine and Neuroendocrine Cancers Berruti, Alfredo Amoroso, Vito Fazio, Nicola neuroendocrine neoplasm neuroendocrine carcinoma Ki67 labeling index Ki67 proliferation index adrenocortical tissues EMT epithelial markers mesenchymal markers recurrence-free survival neuroendocrine neoplasms molecular targeted therapies mTOR inhibitors somatostatin analogs TPH inhibitors meta-analysis medullary thyroid cancer calcitonin MEN2 gene carriers adrenocortical cancer metastatic pheochromocytoma metastatic paraganglioma checkpoint inhibitors avelumab ipilimumab nivolumab pembrolizumab neuroendocrine tumor GEP-NET PET/CT PRRT DOTATOC crcinoid crisis neuroendocrine tumors hemodynamic instability octreotide neuroendocrine molecular profiling targeted therapies mutation fusion ctDNA anaplastic thyroid carcinoma chemotherapy immune checkpoint inhibitors tumors associated macrophages radiotherapy molecular targeted therapy gastroenteropancreatic neuroendocrine neoplasms patient-derived xenograft tumor spheroids somatostatin receptor-2 near infrared-labelled octreotide analog management Delphi consensus pancreatic neuroendocrine tumor everolimus angiogenesis circulating cells biomarkers n/a thema EDItEUR::M Medicine and Nursing thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJC Diseases and disorders::MJCL Oncology Endocrine and neuroendocrine tumors originate from endocrine cells but are heterogeneous in terms of clinical presentation, disease outcome, and treatments available. This Special Issue addresses specific aspects of pre-clinical, clinical, and translational research and clinical management of these diseases with the aim of providing novel insights, addressing current unmet needs, and discussing future treatment perspectives. 2023-02-02T16:34:23Z 2023-02-02T16:34:23Z 2023 book ONIX_20230202_9783036557632_76 9783036557632 9783036557649 https://directory.doabooks.org/handle/20.500.12854/96675 eng image/jpeg Attribution 4.0 International https://mdpi.com/books/pdfview/book/6620 https://mdpi.com/books/pdfview/book/6620 MDPI - Multidisciplinary Digital Publishing Institute 10.3390/books978-3-0365-5764-9 10.3390/books978-3-0365-5764-9 46cabcaa-dd94-4bfe-87b4-55023c1b36d0 9783036557632 9783036557649 198 Basel open access |
| spellingShingle | neuroendocrine neoplasm neuroendocrine carcinoma Ki67 labeling index Ki67 proliferation index adrenocortical tissues EMT epithelial markers mesenchymal markers recurrence-free survival neuroendocrine neoplasms molecular targeted therapies mTOR inhibitors somatostatin analogs TPH inhibitors meta-analysis medullary thyroid cancer calcitonin MEN2 gene carriers adrenocortical cancer metastatic pheochromocytoma metastatic paraganglioma checkpoint inhibitors avelumab ipilimumab nivolumab pembrolizumab neuroendocrine tumor GEP-NET PET/CT PRRT DOTATOC crcinoid crisis neuroendocrine tumors hemodynamic instability octreotide neuroendocrine molecular profiling targeted therapies mutation fusion ctDNA anaplastic thyroid carcinoma chemotherapy immune checkpoint inhibitors tumors associated macrophages radiotherapy molecular targeted therapy gastroenteropancreatic neuroendocrine neoplasms patient-derived xenograft tumor spheroids somatostatin receptor-2 near infrared-labelled octreotide analog management Delphi consensus pancreatic neuroendocrine tumor everolimus angiogenesis circulating cells biomarkers n/a thema EDItEUR::M Medicine and Nursing thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJC Diseases and disorders::MJCL Oncology Endocrine and Neuroendocrine Cancers |
| title | Endocrine and Neuroendocrine Cancers |
| title_full | Endocrine and Neuroendocrine Cancers |
| title_fullStr | Endocrine and Neuroendocrine Cancers |
| title_full_unstemmed | Endocrine and Neuroendocrine Cancers |
| title_short | Endocrine and Neuroendocrine Cancers |
| title_sort | endocrine and neuroendocrine cancers |
| topic | neuroendocrine neoplasm neuroendocrine carcinoma Ki67 labeling index Ki67 proliferation index adrenocortical tissues EMT epithelial markers mesenchymal markers recurrence-free survival neuroendocrine neoplasms molecular targeted therapies mTOR inhibitors somatostatin analogs TPH inhibitors meta-analysis medullary thyroid cancer calcitonin MEN2 gene carriers adrenocortical cancer metastatic pheochromocytoma metastatic paraganglioma checkpoint inhibitors avelumab ipilimumab nivolumab pembrolizumab neuroendocrine tumor GEP-NET PET/CT PRRT DOTATOC crcinoid crisis neuroendocrine tumors hemodynamic instability octreotide neuroendocrine molecular profiling targeted therapies mutation fusion ctDNA anaplastic thyroid carcinoma chemotherapy immune checkpoint inhibitors tumors associated macrophages radiotherapy molecular targeted therapy gastroenteropancreatic neuroendocrine neoplasms patient-derived xenograft tumor spheroids somatostatin receptor-2 near infrared-labelled octreotide analog management Delphi consensus pancreatic neuroendocrine tumor everolimus angiogenesis circulating cells biomarkers n/a thema EDItEUR::M Medicine and Nursing thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJC Diseases and disorders::MJCL Oncology |
| topic_facet | neuroendocrine neoplasm neuroendocrine carcinoma Ki67 labeling index Ki67 proliferation index adrenocortical tissues EMT epithelial markers mesenchymal markers recurrence-free survival neuroendocrine neoplasms molecular targeted therapies mTOR inhibitors somatostatin analogs TPH inhibitors meta-analysis medullary thyroid cancer calcitonin MEN2 gene carriers adrenocortical cancer metastatic pheochromocytoma metastatic paraganglioma checkpoint inhibitors avelumab ipilimumab nivolumab pembrolizumab neuroendocrine tumor GEP-NET PET/CT PRRT DOTATOC crcinoid crisis neuroendocrine tumors hemodynamic instability octreotide neuroendocrine molecular profiling targeted therapies mutation fusion ctDNA anaplastic thyroid carcinoma chemotherapy immune checkpoint inhibitors tumors associated macrophages radiotherapy molecular targeted therapy gastroenteropancreatic neuroendocrine neoplasms patient-derived xenograft tumor spheroids somatostatin receptor-2 near infrared-labelled octreotide analog management Delphi consensus pancreatic neuroendocrine tumor everolimus angiogenesis circulating cells biomarkers n/a thema EDItEUR::M Medicine and Nursing thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJC Diseases and disorders::MJCL Oncology |
| url | ONIX_20230202_9783036557632_76 |